Work Cited: Bahardoust, M., Aghakhani, Z., Mousavi, S., Donyadideh, G., Ziafati, H., Alipour, H., Haghmoradi, M., Olamaeian, F., Tayebi, A., & Tizmaghz, A
The battle between GLP-1 receptor agonists (semaglutide) and dual GLP-1/GIP agonists (tirzepatide) is reshaping both diabetes & obesity treatment
The protective effects of lixisenatide against inflammatory response in human rheumatoid arthritis fibroblast-like synoviocytes
Effect of Semaglutide on Liver Enzymes and Markers of Inflammation in Subjects With Type 2 Diabetes and/or Obesity
Ultimate Custom Massage A massage designed to best meet your individual needs of relaxation, increased circulation or pain relief
Beta blockers, especially non-selective agents, can mask certain hypoglycemia warning signs such as tremor, palpitations, and rapid heartbeat